Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Jun. 27, 2015	Jun. 28, 2014
Operating activities:
Net income	$ 2,706,298	$ 1,934,864
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	917,544	967,081
Provision for losses on accounts receivable	41,956	$ 127,980
Gain on sale of equipment and patents	(45,850)
Increase in cash value of life insurance	(110,567)	$ (167,144)
Deferred compensation	(61,138)	(57,587)
Stock compensation expense	19,978	19,978
Changes in operating assets and liabilities:
Accounts receivable	(1,860,815)	1,757,013
Inventories	546,957	(293,514)
Prepaid expenses and other assets	326,793	(180,299)
Accounts payable and accrued and sundry liabilities	1,525,254	(1,043,177)
Net cash provided by operating activities	4,006,410	3,065,195
Investing activities:
Purchases of property and equipment	(505,085)	$ (528,713)
Proceeds from sale of equipment and patents	47,339
Payments for other assets	(65,592)	$ (68,494)
Net cash used for investing activities	(523,338)	(597,207)
Financing activities:
Dividends paid	(4,302,391)	(1,238,710)
Common stock issued upon exercise of options	180,708	273,397
Net cash used for financing activities	(4,121,683)	(965,313)
Effect of exchange rates on cash	(67,633)	(38,228)
(Decrease)/Increase in cash and cash equivalents	(706,244)	1,464,447
Cash and cash equivalents at beginning of period	6,865,931	5,424,521
Cash and cash equivalents at end of period	$ 6,159,687	$ 6,888,968